JP Patent

JP6615752B2 — Ｂｔｋの置換ニコチンイミド阻害剤およびそれらの調製、ならびにがん、炎症および自己免疫疾患の治療における使用

Assigned to Guangzhou Innocare Pharma Tech Co Ltd · Expires 2019-12-04 · 6y expired

What this patent protects

Patent listed against Brukinsa.

Drugs covered by this patent

Patent Metadata

Patent number
JP6615752B2
Jurisdiction
JP
Classification
—
Expires
2019-12-04
Drug substance claim
No
Drug product claim
No
Assignee
Guangzhou Innocare Pharma Tech Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.